To assess the nature and distribution of cardiovascular abnormalities associated with mixed connective tissue disease, we studied 38 patients with overlapping clinical manifestations of systemic lupus erythematosus, progressive systemic sclerosis and polymyositis, and circulating antibodies to nuclear ribonucleoprotein. The protocol included taking a medical history and a physical examination, an electrocardiogram, a chest roentgenogram, an M mode echocardiogram, and pulmonary function tests. Cardiac catheterization was performed on 17 patients. Postmortem examination was performed on four of the five patients who died during follow-up. Acute pericarditis and/or pericardial effusion was detected in 11 patients (29%) and mitral valve prolapse was identified in 10 patients (26%). Marked intimal hyperplasia of coronary arteries was observed in all four hearts that were autopsied and perivascular and myocardial leukocytic aggregates were present in two hearts. Pulmonary vascular resistance was elevated in 11 of the 17 patients who underwent cardiac catheterization. In summary, cardiovascular abnormalities associated with mixed connective tissue disease include acute pericarditis and/or effusion, mitral valve prolapse, intimal hyperplasia of coronary arteries, From the 1182 and pulmonary hypertension.
perivascular and myocardial leukocytic infiltrates, Circulation 68, No. 6, 1182-1193, 1983. MIXED connective tissue disease (MCTD) is a rheumatic syndrome characterized by the overlapping clinical features of systemic lupus erythematosus (SLE), progressive systemic sclerosis (PSS) and polymyositis (PM), and high titers of circulating antibody to nuclear ribonucleoprotein (RNP).' -Prior studies involving children and sporadic reports of adults with MCTD have suggested that cardiac abnormalities may play a prominent role in the clinical expression and natural history of this rheumatic disorder. In 1972, a prospective multidisciplinary investigation was initiated at the University of Missouri Health Sciences Center to assess the effect of MCTD on various organ systems, including that of the heart. The purpose of this phase of the study was to determine the nature and extent of cardiac abnormalities associated with MCTD.
Methods and materials
Patient selection. Patients were selected for study on the basis of previously described clinical and serologic criteria. '-9 To qualify for the protocol, patients were required to demonstrate overlapping clinical manifestations of SLE, PSS and PM (two or more muscles), and high titers of circulating antibodies toRNP(> 1:10,000).
Serologic studies. Serum was obtained from each patient on several occasions and was analyzed by previously described techniques' for the presence of fluorescent antinuclear antibodies (FANA)I and by a hemagglutination test9 and an immunofluorescence test with Crithidia luciliae26 for presence of antibodies to native DNA. Levels of antibodies directed against nuclear RNP and the Smith (Sm) antigen were determined by hemagglutination -9 and immunodiffusion testing.8 Immunodif-fusion27 was used to determine the presence or absence of the PM-1 antibody (specific for PM or PSS/PM overlap).
Protocol evaluation. Each patient selected for study was admitted to the Clinical Research Center at the University of Missouri Health Sciences Center. A complete medical history and physical examination were performed by members of the cardiology and rheumatology staff. A standard 12-lead electrocardiogram, chest roentgenogram, and pulmonary function tests (to determine arterial blood gases, spirometry, lung volumes, and diffusing capacity of carbon monoxide) were performed on all patients. M mode echocardiography w-as performed in 32 patients (six subjects participated in the protocol before the availability of echocardiography at our hospital). Patients were considered eligible for right heart catheterization if they complained of dyspnea and/or had abnormal pulmonary function test results (this accounted for 85% of the study population). Seventeen patients volunteered for catheterization, which was CIRCULATION performed in the cardiac catheterization laboratory with endhole catheters. Cardiac output was performed by the Fick method. Systemic and pulmonary vascular resistances were calculated by standard formulas.
Statistical methods. Linear (least squares) regressions and correlation coefficients were determined with a Hewlett-Packard 9810 computer to correlate pulmonary vascular resistance with various pulmonary function test results. The chi-square test was used to compare the incidence of mitral valve prolapse in our study population with that in a group of healthy control subjects.
Results
Patient characteristics. Thirty-eight patients were classified as having MCTD (35 women and three men). Their mean (±+ SEM) age was 36.6 + 3.9 years, with a range from 16 to 64 years. The nature and distribution of noncardiac clinical manifestations of patients with MCTD in this study were similar to those reported previously.'
Tests for FANA in all patients were positive and there was a speckled pattern in each case. Titers ranged from 1:160 to 1:5120. Antibodies directed against RNP were present in all subjects in titers ranging from 1:10,000 to 1:1,000,000. Low titers (1:16 to 1:32) of antibodies to double-stranded DNA were transiently detected by hemagglutination testing in only 15% (in our laboratory, this range is not found in normal sera, but can be seen in sera of patients with various rheumatic diseases). Sm antibodies were absent in all but three patients in whom they were transiently detected by hemagglutination (titers 1:512 to 1: 10,000) and immunodiffusion testing. No patient had antibodies to the PM-1 antigen.
Symptoms potentially attributable to cardiac disease.
Symptoms potentially attributable to the cardiovascular system occurred in 32 of the 38 patients with MCTD (table 1) . Dyspnea occurred most commonly but was associated with left heart failure in only one case. Chest pain occurred in 15 patients and was attributed to mitral valve prolapse in five, angina pectoris in three, and pericarditis in two. A chest wall origin of pain was postulated in five patients. Syncope and presyncope occurred in two patients each; both subjects with syncope and one with presyncope were later shown to have pulmonary hypertension. Hemoptysis was noted in one patient with known pulmonary hypertension.
Six patients with MCTD had a history of systemic hypertension. Three subjects had a history of coronary heart disease (definite angina pectoris or prior myocardial infarction confirmed by electrocardiogram or elevation of serum cardiac enzymes).
Cardiovascular examination. Cardiovascular examination revealed abnormality in 30 of the 38 patients with MCTD. Abnormalities are shown in table 2. A heart murmur was audible in 21 patients. Thirteen had a mediumto high-pitched, nonradiating, midsystolic CFive had a history of systemic hypertension and three had a history of ischemic heart disease. murmur located at the upper left sternal border (thought to be a pulmonary flow murmur). Five patients had a late systolic, and one a holosystolic murmur located at the cardiac apex. The presence of mitral valve prolapse was later confirmed by echocardiography in these six individuals. A high-pitched diastolic descrescendo murmur located at the upper left sternal border (presumably pulmonic insufficiency) was audible in two patients who were later shown to have pulmonary hypertension by cardiac catheterization. The pulmonic component of the second heart sound was loud in eight patients. A pulmonic ejection click was audible in two patients and a midsystolic click was present in six. Eleven patients demonstrated gallop rhythm; 10 had a fourth heart sound and two had a third heart sound. Less frequently observed findings included a right ventricular lift, a pericardial friction rub, elevated jugular venous pressure, and systemic hypertension (table 2) . Electrocardiographic abnormalities. Electrocardiograms were abnormal in 25 of the 28 patients with MCTD (table 3) . The most commonly observed abnormalities included right ventricular hypertrophy,28 right atrial enlargement,29 intraventricular conduction block, and repolarization abnormalities; three patients had widespread ST elevation that suggested acute pericarditis. Left ventricular hypertrophy30 and left atrial 1184 enlargement3' were observed infrequently and occuffed exclusively in patients with a history of systemic hypertension or coronary heart disease.
Chest roentgenogram. Cardiovascular abnormalities were evident on chest roentgenograms in 13 of the 38 patients with MCTD (table 4) and 11 had an increased cardiothoracic ratio (> .50). This was attributed to right ventricular enlargement in five patients, left ventricular enlargement in one, and biventricular enlargement in two. The remaining three patients were later shown by echocardiography to have pericardial effusion. Right and left atrial enlargement were suspected in two subjects each. Prominence of the central pulmonary arteries and cephalization of pulmonary veins were observed in one patient each.
Echocardiographic abnormalities. M mode echocardiography was performed on 32 of the 38 patients with MCTD and results showed abnormality in 23 (table 5) . The most commonly observed abnormalities were mitral valve prolapse in eight patients, pericardial effusion in eight (including one with a large pericardial effusion), and right ventricular enlargement in seven.
Systemic and pulmonary hemodynamics. Right heart catheterization with cardiac output determination was performed in 17 patients with MCTD. Hemodynamic data are shown in table 6. Pulmonary vascular resistance was elevated in 11 subjects, mean pulmonary CIRCULATION COccurred in one patient with systemic hypertension and one with coronary heart disease.
artery pressure was increased in 10. and mean pulmonary wedge pressure was elevated in one. Mean arterial pressure was elevated in two subjects and systemic vascular resistance was increased in five patients. Pulmonary vascular resistance was correlated with Pao2, the ratio of forced expiratory volume in 1 sec to forced vital capacity (FEVI/FVC), maximum midexpiratory flow rate, total lung capacity, and diffusing capacity of carbon monoxide. Correlation between increasing pulmonary vascular resistance and progres- Postmortem examination was performed on four of the five patients and pericardial abnormalities were present in three of the four hearts. A large quantity of serosanguinous pericardial fluid and diffuse inflammation of the epipericardial surface was noted on examination of the heart of the patient with cardiac tamponade. There was widespread fibrin deposition and infiltration with polymorphonuclear leukocytes, confirming the presence of acute fibrinous pericarditis (figure 1). In another heart low-grade epipericardial inflammation with areas of revascularization and patchy fibrosis were observed at autopsy. These findings suggested resolving pericarditis. A third heart exhibited multiple areas of epipericardial fibrosis (in the absence of coronary artery disease), which suggested prior episodes of acute pericarditis. All four hearts that were autopsied showed intimial proliferation in the epicardial and intramural coronary arteries (figure 2). These abnormalities were most pronounced in the two youngest patients (ages 18 and 24). Intimal proliferation was accompanied by an increase in the acellular elements of the intima and media (presumably mucopolysaccharides). These coronary vascular abnormalities occurred in most, but not all, of the coronary arteries examined. There were no coronary artery thrombi or intimal plaques that would suggest atherosclerosis. There was no pathologic evidence of myocardial infarction; specifically, there was no myocardial fibrosis in the distribution of the affected arteries. Two of the hearts showed sporadic cellular infiltrates in the perivascular space surrounding intramural coronary arteries and in adjacent myocardium. The infiltrate was lymphocytic in one and consisted of lymphocytes and polymorphonuclear leukocytes in the other (figure 3).
All three patients with pulmonary hypertension had intimal proliferation of small pulmonary arteries and arterioles. One lung showed fibrin microthrombi in small pulmonary arteries and arterioles; we are not certain whether they were caused by embolism or in situ thrombosis. Smooth muscle hypertrophy was present in muscular pulmonary arteries in each of these three patients ( figure 4) . The remaining patient, who did not have pulmonary hypertension, had normal pulmonary arteries and arterioles. Three of the lungs that were autopsied showed areas of mild fibrosis. Sporadic lymphocytic infiltrates were present in a lung of one patient. The proliferative vascular lesions were most miarked in patients with mioderate-to-severe pulmonary hypertension. In severe enough in these patients to account for the clevated pulmonary vascular resistance.
Relationship of key cardiovascular abnormalities to clinical overlap subsets. -p-. Pericardial abnormalities were detected by clinical or laboratory methods in II patients (29%) and were present in three of the four hearts that were autopsiecd. Prior studiles of patients with MCTD have reported a 15% to 38% incidence of pericarditis in adults and a 43% incidence in children.-3 1`6 Studies of patients with SLE have reported a 25% incidence of clinically evident pericarditis, a 50% incidence of pericardial effusion (detected by echocardiography), and an 80% incidence of pericardial abnormalities at autopsy. 7 Pericardial involvement has been reported to occur in up to 62% of patients with PSS 3-39 but is a rare manifestation of PM.4' "' In this study, pericardial abnormalities were identified more readily by electrocardiography (ST elevation) and echocardiography (pericardial effusion) than by clinical manifestations (pericardial friction rub, chest pain). As in prior reports, pericardial effusions were usually of small mag-nitLude and not hemodynamically significant. The occurrence of massive pericardial effusion leading to cardiac tamponade in one patient, however, underscores the lethal potential of this complication. Prior Vol. 68, No. 6. December 1983 reports have suggested that pericarditis associated with MCTD may be responsive to treatment with corticosteroids.3 6 0 Our experience of rapid clinical im provement and/or resolution of pericardial effusion on echocardiogram in six of seven patients treated with corticosteroids supports these observations. Mitral valve prolapse was identified by clinical and/ or echocardiographic means in 10 patients (26%). We compared the incidence of mitral valve prolapse in our study population with that in a control population (of similar age and sex distribution) consisting of 110 healthy asymptomatic individuals.42 The incidence of mitral valve prolapse in the control population was 10%. The difference between the incidence of mitral valve prolapse in our study population and the control group was significant (p < .05). The pathogenesis of mitral valve prolapse in patients with MCTD is unknown. Although mitral valve prolapse occurred significantly more frequently in our study population than in the comparable healthy control population, its wide prevalence in the general population precludes assignment of a cause/effect relationship with MCTD in each tr ,$ ¢v #e n~'* FIGURE 4. Small pulmonary artery in an 8-year-old woman with MCTD and pulmnonary hypertension. Note the presence of marked smooth muscle hypertrophy and mild-to-moderate intimal proliferation (heniatoxylin and cosin stain, x 2(10)).
case. SLE is frequently listed among the causes of mitral valve prolapse, but prolapse has not been reported to occur with disproportionate frequency in several large series of patients with SLE.36 Mitral valve prolapse has not been associated with PSS or PM and has not been previously reported in patients with MCTD. Five of our 10 patients with mitral valve prolapse had chest pain; one had palpitations and one presyncope. Mitral valve prolapse was detected by physical examination and echocardiography in seven patients, by physical examination alone in one, and by echocardiography alone in two. Ambulatory electrocard iographic monitoring was not performed routinely; thus, we are unable to comment on the incidence and nature of related cardiac arrhythmias. Other known complications of mitral valve prolapse, such as sudden death, congestive heart failure due to mitral regurgitation, cerebral eim-bolism, and infective endocarditis, were not observed in this study. Neither verrucous endocardial valvular lesions (such as are observed in SLE) nor thickened valves (as seen in PSS) were present on postmortem examination. Intimal hyperplasia involving epicardial and intramural coronary arteries was noted in all four hearts that were autopsied. Singsen et al. 14 1 ' previously reported similar abnormalities in the hearts of two children with MCTD and Cooke and Lurie"7 noted the presence of intimal thickening of intramyocardial coronary arteries in a 22-year-old woman with MCTD. The coronary vascular abnormalities noted in our patients were morphologically similar to those observed in patients with PSS, except that the vascular proliferative lesions in PSS are usually confined to small coronary arteries and arterioles.'8 I '9,44 Intimal hyperplasia has not been described in SLE and coronary artery abnormalities have not been reported in PM. In this study the hearts that were autopsied did not demonstrate contractionband necrosis or myocardial fibrosis, two abnormalities commonly associated with PSS. 39, 43Xs Cellular infiltrates in the perivascular spaces of intramural coronary arteries and adjacent myocardium were present in two of the four hearts; these included sporadic aggregates of lymphocytes and polymorphonuclear leukocytes in one (figure 3) and lymphocytes alone in the other. These abnormalities occurred without evidence of congestive heart failure, ventricular ectopic activity, coronary vasculitis, or septicemia.
Singsen et al. 3 15 reported similar histologic abnormalities in two children with MCTD who died of noncardiac causes; such cellular aggregates may represent low-grade myocarditis. Prior reports of myocardial inflammation in MCTD suggest that the courses and prognosis is not always as benign as observed in outpatients. Whitlow et al. '9 reported the case of an 18-yearold woman with progressive congestive heart failure associated with chest pain, fever, tachycardia, and ventricular ectopic activity that culminated in death. The presence of lymphocytic infiltration of the myocardium confirmed the clinical diagnosis of myocarditis. Howard20 described an 11-year-old girl with MCTD and clinical myocarditis who died suddenly during a disease flare and Oetgen et al.'2 described a patient with MCTD with clinical and echocardiographic evidence of dilated cardiomyopathy. Despite these deaths, our results and those of Singsen et al. suggest that widespread myocardial damage is an unusual complication of MCTD. Clinically evident myocarditis occurs in approximately 10% of patients with active SLE, but has been detected in 42% of autopsied hearts. 36, 37 Leukocytic aggregates similar to those noted in our patients have been observed in some patients; however, morphologically distinct fibrinoid myocardi-Vol. 68, No. 6, December 1983 al lesions have been observed more frequently.37 Aggregates of mononuclear cells unrelated to blood vessels have been reported in patients with PM. 40, 41 Sporadic leukocytic infiltrates rarely occur in PSS.43X5
Abnormalities of cardiac conduction are known to occur in PSS, PM, and SLE. 36 4'45 Two prior reports suggest that patients with MCTD may also be at risk for developing conduction abnormalities. Emlen2' reported a case of infranodal complete atrioventricular block preceded by new left bundle branch block during a flare of systemic vasculitis. Nolan22 described complete atrioventricular block in the infant of a mother with MCTD and suggested that transplacental transfer of antibody might be responsible for the conduction abnormality. Five patients in our study demonstrated evidence of abnormal cardiac conduction and intraventricular conduction block was present in each case. Of these, three patients had complete or incomplete right bundle branch block and pulmonary hypertension. There were no cases of atrioventricular block and the one conduction system examined in detail at autopsy was normal. Our results suggest that conduction system abnormalities do not occur routinely in patients with MCTD. When present, such abnormalities can often be attributed to other causes; however, definitive assessment of the nature and prevalence of conduction system disease in MCTD would require ambulatory monitoring, electrophysiologic testing, and longitudinal follow-up.
Pulmonary hypertension appears to be a common complication of MCTD. Its presence in this study was confirmed in 11 patients by cardiac catheterization and was suspected clinically in two others. The pathogenesis of pulmonary hypertension in persons with MCTD is uncertain. Previous reports describing the lung histology of patients with MCTD have noted a variety of abnormalities, including interstitial fibrosis, interstitial mononuclear infiltrates, and intimal proliferation in pulmonary arterioles. 23 25 Such abnormalities could produce a significant decrease in the cross-sectional area of the pulmonary arteriolar bed that would result in pulmonary hypertension, or could cause hypoxia with resultant vasoconstriction of pulmonary resistance vessels. The relatively mild nature of pulmonary interstitial abnormalities in our patients with elevated pulmonary vascular resistance suggests that such abnormalities played little or no role in the genesis of pulmonary hypertension. Moreover, the low incidence of left ventricular failure and the poor correlation between increasing pulmonary vascular resistance and Pao2 mitigate against an important role for these factors in the evolution of pulmonary hypertension. In 1191 contrast, intimal hyperplasia of pulmonary arteries and arterioles was present in all three patients with pulmonary hypertension from whom lung tissue was available and was absent in the one patient with normal pulmonary hemodynamic characteristics. The severity of this proliferative vascular abnormality tended to parallel the severity of pulmonary hypertension. Thus, the presence of pulmonary hypertension appears to be most clearly related to the proliferative vascular abnormalities involving small pulmonary arteries and arterioles ( figure 4) . Pulmonary hypertension is extremely common in patients with PSS, particularly in those with the CREST variant. 46 47 It may evolve from extensive pulmonary fibrosis (74%) or from proliferative vascular lesions similar to those observed in our patients (29%).39 48 Pulmonary fibrosis is generally more severe in patients with PSS than it was in our patients. 39 44.48 Such lesions occur infrequently in SLE and PM.
Clinical assessment and noninvasive laboratory tests proved to be insensitive indicators of pulmonary hypertension. Dyspnea was present in all patients with increased pulmonary vascular resistance confirmed by right heart catheterization, but was also present in five of six subjects with normal pulmonary hemodynamic characteristics. Physical findings that suggested pulmonary hypertension (loud pulmonic closure sound, right ventricular lift, murmur of pulmonic valve insufficiency) occurred with moderate frequency in patients with documented elevation of pulmonary vascular resistance. Roentgenographic and echocardiographic evidence of pulmonary hypertension was rarely seen. The poor correlation between increasing pulmonary vascular resistance and progressively impaired lung function, as determined by Pao2, forced expiratory volume in I sec/forced vital capacity, maximum midexpiratory flow rate, total lung capacity, and diffusing capacity of carbon monoxide indicates that cross-sectional assessment of pulmonary function does not reliably discriminate between patients with MCTD with pulmonary hypertension and those with normal pulmonary hemodynamic characteristics.
Pulmonary hypertension was present and was moderate to severe in three of the five patients who died. In one case, pulmonary hypertension clearly played an integral role in the death of the patient, and it was thought to play a facilitating role in two other deaths. Thus, patients with MCTD and moderate-to-severe pulmonary hypertension appear to be at higher risk than those with normal pulmonary hemodynamic characteristics.
Although there was a trend for MCTD patients with PSS/PM overlap features to have less cardiovascular abnormalities than those in the other clinical overlap subsets, the small number of patients available in each subset precludes a more definitive statement. The clinical and serologic findings in our patients with rheumatic disease did not provide clues as to the pathogenesis of cardiovascular abnormalities. In summary, cardiovascular abnormalities associated with MCTD include: (l) acute pericarditis with or without pericardial effusion, (2) mitral valve prolapse, (3) intimal hyperplasia of coronary arteries, (4) perivascular and myocardial leukocytic infiltrates, and (5) pulmonary hypertension. Whether the conduction system abnormalities noted in this and other studies are related to MCTD is uncertain. Other cardiovascular abnormalities observed in this investigation were either nonspecific or could be attributed to other causes, e.g., coronary artery disease and systemic hypertension. Our results suggest that cardiovascular abnormalities occur commonly in MCTD and play an important role in the clinical expression and natural history of this rheumatic syndrome.
